DAPAGLIFLOZIN

Clinical Indication

With insulin for treating Type 1 diabetes

Comments

In line with NICE TA597

Implementation date 28th November 2019

Date of classification

November 2019

Review date

November 2019

Amber SIMPLE

Drugs suitable to be initiated and prescribed in primary care only after specialist assessment and recommendation. A shared care agreement is not required.